Pricing in Indian private healthcare: what you can shape
The front desk at a hospital unit, late evening. A patient’s son is negotiating the surgical package with the billing executive, who has discretionary authority up to a point and a phone number for the unit head beyond it. A consultant has already written “please consider” on the estimate. By the time the admission is confirmed, the price of the procedure is different from the one in the rate card, different from the one the brochure implied, and different from the one the CFO modelled. Nobody in the building decided to cut the price. It happened.
Pricing in Indian private healthcare is discussed in boardrooms as if the hospital sets it. In practice the hospital sets a small and shrinking share of it. The rest is set by insurers, third-party administrators, government schemes, corporate contracts and the patient’s own family, and the growth leader who does not understand which is which will spend a year pulling levers that are not connected to anything.
This is what I have learned about who actually sets the price, where a growth leader can move it, and where the movement is pretend.
Who actually sets the price
Think of the hospital’s price as layers, from the floor up.
At the bottom sit government scheme tariffs: fixed, published, non-negotiable at the unit level, and for many procedures below the hospital’s fully loaded cost. The unit’s only decision is whether to be empanelled and for which procedures.
Above them sit insurer and TPA tariffs, negotiated at group or unit level, renewed on a cycle, and applied to a growing majority of planned admissions in Tier 1 cities. These are the effective price for insured patients, and they are negotiated by a commercial team against the payer’s network managers, with volume, accreditation and claims history as the currency.
Above those sit corporate contracts, which often reference the TPA tariff with a discount or a room-category cap, and international packages, priced from the rack rate for facilitators who know exactly what the competing hospitals charge.
At the top sits the rack rate, which almost nobody pays, and the cash package, which is what the front desk actually negotiates.
The hospital sets the top layer fully, the middle layers partially, and the bottom layer not at all. The volume is distributed the other way round. That inversion is the pricing problem in one sentence.
Package pricing and where it breaks
Packages exist because patients and payers want a single number, and because the alternative — an itemised estimate that grows during the stay — destroys trust faster than any price level does.
A well-built package prices the procedure, the standard length of stay, the standard consumables and the consultant fee, with the room category as the variable that moves the total. It is the closest thing the hospital has to a real price, and it is where a growth leader can do actual work: which procedures to package, how to structure the room-category ladder, what to exclude and how clearly.
Packages break in predictable ways. The stay runs beyond the package days and the extension is itemised at rack rate, which the family experiences as bait and switch. Implants and high-value consumables sit outside the package and are not explained until the bill. A complication converts a package case into an itemised one, and nobody told the family that this could happen. Every one of these produces a discount request at discharge, a complaint on a review site, or both, and the price the hospital eventually collects is lower than the one it quoted — for reasons that were entirely predictable at the time of the quote.
The fix is not a different price. It is a better estimate, with the exclusions and the conversion rules explained in a language the family reads, before admission. This is dull operational work, and it is worth more to yield than any pricing strategy I have seen presented to an executive committee.
The payer-negotiated floor
The TPA tariff is where the real price of a Tier 1 hospital is set, and it is set in a meeting the growth leader is usually not in.
The negotiation is volume against rate. The payer offers network position — being on the preferred list, being a cashless option, being recommended by their call centre — in exchange for a tariff below rack. The hospital offers accreditation, claims discipline and capacity. The tariff that results becomes the effective price for that payer’s patients, and if the payer’s patients are a large share of planned admissions, it becomes the effective price of the hospital.
Two things go wrong. The first is that the volume promised in the negotiation does not arrive, and the hospital has agreed a floor for nothing. The second is that the tariff is set at group level for a Tier 1 flagship’s cost base and then applied to a Tier 2 unit with a different one, where it is either uncompetitive or loss-making.
The growth leader’s job here is to be in the room with the numbers that matter: which specialties this payer actually sends, at what conversion, and what capacity we are committing. A tariff negotiated without the demand data behind it is a guess dressed as a contract. The first time I brought that data into a renewal, the commercial team was mildly irritated and then, by the second meeting, asked for it as standard.
Scheme tariffs and the empanelment decision
Government schemes are the political price. They are set for access, not margin, and the hospital’s only real decision is which procedures to accept at which units.
That decision is genuinely hard. Scheme volume fills beds in a Tier 2 unit that would otherwise sit empty, and builds a reputation in a district faster than any campaign. It also displaces cash and insured patients at a unit near capacity, ages the receivables in a way finance cannot control, and can quietly turn a specialty’s contribution negative once the case mix tilts.
The honest way to make the decision is by unit, by specialty and by occupancy, with a review every year. A new Tier 2 unit and a full Tier 1 flagship should not have the same answer, and a group that gives them the same answer for administrative convenience is paying for that convenience in margin.
Cash patients: the only pure price
The cash patient is the one segment where the hospital sets the price and the patient decides. It is also the segment that is shrinking as insurance penetration grows, and the one most exposed to the discounting culture.
For cash patients, the real pricing lever is the room category, not the procedure. The same surgery in a general ward, a twin-sharing room and a single suite carries three different totals, and the family self-selects. A well-designed ladder — clear differences, clear pricing, visible upgrades — lets the hospital capture willingness to pay without negotiating. A badly designed one, where the categories are indistinct or the differentials feel arbitrary, pushes every family to the cheapest option and then to the discount desk.
The other lever is the estimate itself. A cash family that receives a clear, complete estimate with a small range converts at the quoted price. One that receives a vague number and an itemised surprise converts at a discount or not at all.
Transparency pressure
Pricing transparency in Indian healthcare is arriving from three directions at once: regulators asking for published rate cards, review sites full of bill complaints, and insurers whose apps show patients what the network rate is before they walk in.
None of this makes the price itself the problem. The damage in every case I have seen came from the gap between the estimate and the final bill, not from the level of either. A hospital whose bills match its estimates can charge a premium and defend it. One whose bills run over its estimates, however competitive the original number, is a pricing scandal waiting for a viral post.
The growth leader should read estimate-to-bill variance as a pricing metric, not a billing one. It is the number that determines whether the price you publish is the price you are believed to charge.
The discounting culture at the front desk
This is the part of pricing that actually happens, and it is the one no pricing strategy deck addresses.
Discounts in a hospital come from several places. A billing executive has a discretionary band. A unit head has a larger one. A consultant asks for a reduction for a patient he knows, and the request is very hard to refuse. A family negotiates at admission and again at discharge. A complaint is settled with a goodwill reduction. A “reference” — someone who knows someone — comes with an expectation. Each of these is small and reasonable. Together they are a price cut of a size that would never be approved as a pricing decision.
I have sat in reviews where the discount line was larger than the marketing budget, and nobody in the room owned it. Finance recorded it. Operations granted it. Marketing had brought in the patients who received it. The growth leader is the natural owner precisely because nobody else wants to be.
The mechanism that works is not a ban, which drives discounting underground. It is a register: every discount, its amount, its reason and its approver, reviewed monthly with the unit head and the medical director. Discretionary bands narrow once they are visible. Consultant-requested discounts fall once the consultants see their own totals. The goodwill reductions expose the operational failures that caused the complaints. Visibility does most of the work; policy does the rest.
Where you can move price and where you are pretending
You can move the room-category ladder and the mix of patients across it. You can move the package design — what is in, what is out, how conversions are handled. You can move the estimate discipline and the estimate-to-bill variance. You can move the discount line through governance. You can move the payer mix, slowly, by which empanelments you pursue and which you let lapse, and you can bring demand data into the tariff negotiation so that the floor is set against volume that will actually arrive. You can move the specialty mix towards procedures where the hospital has pricing power because the outcomes are visibly better.
You cannot move scheme tariffs. You cannot move a TPA tariff already signed for the cycle. You cannot move implant and consumable costs that a supplier sets. You cannot price a commodity procedure above the market in a city where three competitors publish lower rates. A growth leader who presents a pricing strategy built on these is presenting a wish list.
The honest test is to ask, for every pricing lever on the slide, who has to agree before it moves. If the answer is a government department, an insurer’s network manager or a supplier, the lever is not yours.
The order of operations
- Build the discount register first. Every discount, amount, reason, approver. Review monthly. This is the largest recoverable price lever in most units and it needs no negotiation with anyone outside the building.
- Measure estimate-to-bill variance by unit and specialty. Set a target for the share of cases that close within the estimate range.
- Rebuild the package exclusions and conversion rules in plain language, in the regional language as well as English, and put them in the family’s hands before admission.
- Redesign the room-category ladder at one unit where the categories are indistinct. Watch the mix move before touching the others.
- Get into the next TPA renewal with demand data by specialty. Argue for volume commitments, and for tariffs that differ between Tier 1 and Tier 2 units.
- Review scheme empanelment by unit and specialty against occupancy and contribution. Decide, and write the decision down.
- Only then present a pricing strategy. It will be shorter than the one you would have written first, and every lever on it will actually move.
Most hospital pricing strategies are a description of what other people decided. The part you own is smaller, and it is worth more than the slide.
Questions people ask
Think of it as layers. At the bottom, government scheme tariffs: fixed, published, often below fully loaded cost. Above them, insurer and TPA tariffs negotiated at group or unit level, which are the effective price for most planned admissions in Tier 1 cities. Then corporate contracts and international packages. At the top, the rack rate almost nobody pays and the cash package the front desk negotiates. The hospital sets the top fully, the middle partially, the bottom not at all.
A package prices the procedure, standard length of stay, standard consumables and consultant fee, with room category as the variable. It exists because patients and payers want one number. It breaks when the stay runs over and the extension is itemised at rack rate, when implants sit outside and are not explained until the bill, and when a complication converts the case to itemised billing and nobody warned the family. Each produces a discount request at discharge or a complaint online.
The rate a hospital agrees with an insurer or third-party administrator for that payer’s patients, in exchange for network position — being on the preferred list, a cashless option, recommended by their call centre. It is negotiated on volume against rate, with accreditation, claims discipline and capacity as the hospital’s currency. If that payer’s patients are a large share of planned admissions, the TPA tariff becomes the effective price of the hospital, set in a meeting the growth leader is usually not in.
The room-category ladder and the mix of patients across it. Package design — what is in, what is out, how conversions are handled. Estimate discipline and estimate-to-bill variance. The discount line, through governance. Payer mix, slowly, through which empanelments you pursue. Demand data brought into tariff negotiations. And specialty mix towards procedures where outcomes give you pricing power. The honest test for any lever: who has to agree before it moves? If it is a government, an insurer or a supplier, it is not yours.
A record of every discount granted in a unit — amount, reason and approver — reviewed monthly with the unit head and the medical director. It is the largest recoverable price lever in most units and needs no negotiation with anyone outside the building. Discretionary bands narrow once they are visible. Consultant-requested discounts fall once consultants see their own totals. Goodwill reductions expose the operational failures behind the complaints. Visibility does most of the work; policy does the rest.
By unit, by specialty and by occupancy, reviewed every year, with the decision written down. Scheme volume fills beds in a Tier 2 unit that would otherwise sit empty and builds a district reputation faster than any campaign. It also displaces cash and insured patients at a unit near capacity, ages receivables and can turn a specialty’s contribution negative once the case mix tilts. A new Tier 2 unit and a full Tier 1 flagship should not have the same answer.
Because in every pricing complaint I have seen, the damage came from the gap between the estimate and the final bill, not from the level of either. A hospital whose bills match its estimates can charge a premium and defend it. One whose bills run over, however competitive the quote, is a viral post waiting to happen. Read variance as a pricing metric, not a billing one: it decides whether the price you publish is the price you are believed to charge.
For cash patients, the room category is the real lever, not the procedure. The same surgery in a general ward, a twin-sharing room and a single suite carries three totals, and the family self-selects. A well-designed ladder with clear differences and visible upgrades captures willingness to pay without negotiating. A badly designed one, where categories are indistinct or differentials feel arbitrary, pushes every family to the cheapest option and then to the discount desk. Redesign it at one unit first.
Not with a ban, which drives discounting underground. A consultant writing please consider on an estimate for a patient he knows is very hard to refuse, and each request is small and reasonable. Put every one in the register with the consultant’s name, and review the totals monthly with the medical director in the room. Consultant-requested discounts fall once consultants see their own totals side by side. The medical director’s ownership of that review is what makes it stick.
Which specialties this payer actually sends, at what conversion from enquiry to admission, and what capacity the hospital is committing. A tariff negotiated without demand data is a guess dressed as a contract, and the volume promised in the room often never arrives. Argue for volume commitments and for tariffs that differ between Tier 1 and Tier 2 units. The first time I brought this data the commercial team was mildly irritated; by the second meeting they asked for it as standard.
The growth leader, precisely because nobody else wants to. I have sat in reviews where the discount line was larger than the marketing budget and nobody in the room owned it. Finance recorded it, operations granted it, marketing had brought in the patients who received it. The mechanism is the register and the monthly review with the unit head and medical director. Ownership here is less about authority than about being the person who makes it visible.
No. A common failure is a tariff set at group level for a Tier 1 flagship’s cost base and then applied to a Tier 2 unit with a different one, where it is either uncompetitive or loss-making. The same is true of scheme empanelment. A group that gives all its units the same answer for administrative convenience is paying for that convenience in margin. Negotiate by unit where the payer will allow it, and bring the unit’s own demand data.
The discount register shows movement within a quarter, because visibility alone narrows discretionary bands. Estimate-to-bill variance takes a quarter or two to measure and target by unit and specialty. Package exclusions and the room ladder move mix within a couple of cycles at the pilot unit. TPA tariffs move only at renewal, and scheme decisions annually. Sequence it that way, and only then write the pricing strategy — it will be shorter, and every lever on it will actually move.
Transparency is arriving from three directions — regulators asking for published rate cards, review sites full of bill complaints, and insurer apps showing patients the network rate before they walk in. None of it makes the price level the problem. What it punishes is the gap between estimate and bill. Hospitals with disciplined estimates and plain-language package exclusions, in the regional language as well as English, will find transparency defends a premium rather than eroding it.
